ProShare Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $1.19M | Sell |
|
|||||
|
2024
Q4 | $1.07M | Buy |
|
|||||
|
2024
Q3 | $874K | Buy |
|
|||||
|
2024
Q2 | $620K | Sell |
|
|||||
|
2024
Q1 | $776K | Buy |
|
|||||
|
2023
Q4 | $710K | Buy |
|
|||||
|
2023
Q3 | $535K | Buy |
|
|||||
|
2023
Q2 | $510K | Buy |
|
|||||
|
2023
Q1 | $419K | Sell |
|
|||||
|
2022
Q4 | $595K | Buy |
|
|||||
|
2022
Q3 | $297K | Buy |
|
|||||
|
2022
Q2 | $239K | Sell |
|
|||||
|
2022
Q1 | $378K | Sell |
|
|||||
|
2021
Q4 | $430K | Sell |
|
|||||
|
2021
Q3 | $383K | Sell |
|
|||||
|
2021
Q2 | $942K | Buy |
|
|||||
|
2021
Q1 | $712K | Buy |
|
|||||
|
2020
Q4 | $969K | Buy |
|
|||||
|
2020
Q3 | $670K | Sell |
|
|||||
|
2020
Q2 | $798K | Buy |
|
|||||
|
2020
Q1 | $372K | Sell |
|
|||||
|
2019
Q4 | $1.12M | Buy |
|